Abstract
The diagnosis and treatment of interstitial cystitis (IC) has frustrated both clinicians and patients alike. Interstitial cystitis is a bladder disease characterized by urinary frequency, urgency, and pelvic pain, first described more than 80 years ago. Until recently, it has been an ignored disease; patients with IC have been told that their symptoms are imaginary and that there is nothing wrong with them. IC patients have been counseled to seek psychiatric help for their disease, and many patients suffer unduly until a diagnosis is made. Although IC has been considered to be a disease that predominantly affects women, more men are now being diagnosed with this disease. There is evidence that men treated for “chronic abacterial prostatatis”—which is characterized by urinary frequency, urgency, and pelvic/perineal pain—will often have cystoscopic findings suggestive of interstitial cystitis and will respond to standard treatments for IC. The problem with IC is that it is a diagnosis of exclusion, and there are no specific objective tests to definitively diagnosis IC or to monitor disease progression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected Reading
Baskin LS, Tanagho EA (1992) Pelvic pain without pelvic organs. J Urol 147: 683–686.
Christmas TJ, Bottazzo GF (1992) Abnormal urothelial HLA-DR expression in interstitial cystitis. Clin Exp Immunol 87: 450–454.
Fleischmann J (1994) Calcium channel antagonists in the treatment of interstitial cystitis. Urol Clin N Am 21: 107–111.
Fleischmann JD, Huntley HN, Shingleton WB, Wentworth DB (1991) Clinical and immunological response to nifedipine for the treatment of interstitial cystitis. Interleukin-2 inhibitor was measured using an IL-2 dependent cell line. Urinary IL-2 inhibitor activity was normal in 7 of 9 subjects regardless of symptom severity. J Urol 146: 1235–1239.
Goin JE, Olaleye D, Peters KM, Steinert B, Habicht K, Wynant G (1998) Psychometric analysis of the University of Wisconsin interstitial cystitis scale: implications for use in randomized clinical trials. J Urol 159: 1085–1090.
Hanno P, Levin RM, Monson FC, Teuscher C, Zhou ZZ, Ruggieri M, Whitmore K, Wein AJ (1990) Diagnosis of interstitial cystitis. J Urol 143: 278–281.
Hanno PM (1997) Analysis of long-term Elmiron therapy for interstitial cystitis. Urology 49 (5A Suppl): 93–99.
Hanno PM, Landis JR, Matthews-Cook Y, Kusek J, Nyberg L, Jr (1999) The diagnosis of interstitial cystitis: lessons learned from the National Institutes of Health interstitial cystitis database study. J Urol 161: 553–557.
Holm-Bentzen M, SOndergaard I, Hald T (1987) Urinary secretion of a metabolite of histamine (1,4methyl-imidazole-acetic-acid) in painful bladder disease. Br J Urol 59: 230–233.
Hunner GL (1915) A rare type of bladder ulcer in women: report of cases. Boston Med Surg J 172: 660–664.
Joustra B, Karrenbeld A, Mensink H (1996) Specific auto-antibodies in interstitial cystitis patients suggest an auto-immune etiology. J Urol 155: 431A (Abstract).
Keay S, Zhang C-O, Trifillis AL, Hebel JR, Jacobs SC, Warren JW (1997) Urine autoantibodies in interstitial cystitis. J Urol 157: 1083–1087.
Keller ML, McCarthy DO, Neider RS (1994) Measurement of symptoms of interstitial cystitis. A pilot study. Urol Clin N Am 21: 67–71.
Korting GE, Smith SD, Wheeler MA, Weiss RM, Foster HE, Jr (1999) A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol 161: 558–565.
La Rock DR, Sant GR (1995) Intravesical chlorpactin for refractory interstitial cystitis. Infections in Urology September/October:151–157.
Liebert M, Wedemeyer G, Stein JA, Washington R, Jr, Faerber G, Flint A, Grossman HB (1993) Evidence for urothelial cell activation in interstitial cystitis. J Urol 149: 470–475.
Lotz M, Villiger P, Hugli T, Koziol J, Zuraw BL (1994) Interleukin-6 and interstitial cystitis. J Urol 152: 869–873.
O’Leary MP, Sant GR, Fowler FJ, Whitmore KE, Spolarich-Kroll J (1997) The interstitial cystitis symptom index and problem index. Urology 49 (Suppl 5A): 58–63.
Ochs RL, Stein TW, Jr, Peebles CL, Gittes RF, Tan EM (1994) Autoantibodies in interstitial cystitis. J Urol 151: 587–592.
Parkin J, Shea C, Sant GR (1997) Intravesical dimethyl sulfoxide (DMSO) for interstitial cystitis—a practical approach. Urology 49 (5A Suppl): 105–107.
Parsons CL (1996) Potassium sensitivity test. Tech Urol 2: 171–173.
Parsons CL (1997) New concepts in interstitial cystitis. Int Urogynecol J Pelvic Floor Dysfunct 8: 1, 2.
Parsons CL, Benson G, Childs SJ, Hanno P, Sant GR, Webster G (1993) A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J Urol 150: 845–848.
Peters K, Diokno A, Steinert B, Yuhico M, Mitchell B, Krohta S, Gillette B, Gonzalez J (1996) The efficacy of intravesical Tice® bacillus Calmette-Guérin (BCG) in the treatment of interstitial cystitis (IC): a double-blind, prospective, placebo controlled trial. J Urol 157: 2090–2094.
Peters KM, Diokno AC, Steinert BW (1999) A preliminary study on urinary cytokine levels in interstitial cystitis: does intravesical BCG treat IC by altering the immune profile in the bladder? Urology,in press.
Peters KM, Diokno AC, Steinert BW, Gonzalez JA (1998) The efficacy of intravesical TICE® bacillus Calmette-Guérin (BCG) in the treatment of interstitial cystitis (IC): long-term follow-up. J Urol 159: 1483–1487.
Ratner V, Slade D, Greene G (1994) Interstitial cystitis. A patient’s perspective. Urol Clin North Am 21: 1–5.
Sant GR (1987) Intravesical 50% dimethyl sulfoxide (RIMSO-50) in treatment of interstitial cystitis. Supplement to Urology 29: 17–21.
Sant GR, Theoharides TC (1994) The role of the mast cell in interstitial cystitis. Urol Clin North Am 21: 41–53.
Silk MR (1970) Bladder antibodies in interstitial cystitis. J Urol 103: 307–309.
Smith SD, Wheeler MA, Foster HE, Jr, Weiss RM (1996) Urinary nitric oxide synthase activity and cyclic gmp levels are decreased with interstitial cystitis and increased with urinary tract infections. J Urol 155: 1432–1435.
Smith SD, Wheeler MA, Foster HE, Jr, Weiss RM (1997) Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine. J Urol 158: 703–708.
Theoharides TC, Sant GR (1997) Hydroxyzine therapy for interstitial cystitis. Urology 49 (5A Suppl):108–110.
Theoharides TC, Sant GR, El-Mansoury M, Letourneau R, Ucci AA, Jr, Meares EM, Jr (1995) Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study. J Urol 153: 629–639.
Waxman JA, Sulak PJ, Kuehl TJ (1998) Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 160: 1663–1667.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peters, K.M., Diokno, A.C. (2001). The Diagnosis and Treatment of Interstitial Cystitis. In: Kursh, E.D., Ulchaker, J.C. (eds) Office Urology. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-010-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-59259-010-0_11
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-188-2
Online ISBN: 978-1-59259-010-0
eBook Packages: Springer Book Archive